Inappropriate subcutaneous implantable cardioverter-defibrillator shocks due to T-wave oversensing can be prevented: Implications for management

Heart Rhythm

Volumn 11, Issue 3, 2014, Pages 426-434

  Kooiman, Kirsten M ^a   Knops, Reinoud E ^a   Olde Nordkamp, Louise ^a   Wilde, Arthur A M ^a   De Groot, Joris R ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

ICD programming; ICD sensing; Implantable cardioverter defibrillator; Inappropriate shocks; Subcutaneous ICD; T wave oversensing

Indexed keywords

ICD PROGRAMMING; ICD SENSING; IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; INAPPROPRIATE SHOCKS; SUBCUTANEOUS ICD; T-WAVE OVERSENSING;

ADULT; ALGORITHMS; ARRHYTHMIAS, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; PROSTHESIS FAILURE; RISK FACTORS;

EID: 84894545754     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2013.12.007     Document Type: Article

References (21)

1. J.A. Ezekowitz, P.W. Armstrong, and F.A. McAlister Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized, controlled trials Ann Intern Med 138 2003 445 452
2. G.H. Bardy, W.M. Smith, and M.A. Hood et al. An entirely subcutaneous implantable cardioverter-defibrillator N Engl J Med 363 2010 36 44
3. R.T. Borne, P.D. Varosy, and F.A. Masoudi Implantable cardioverter-defibrillator shocks: epidemiology, outcomes, and therapeutic approaches JAMA Intern Med 173 2013 859 865
4. M.R. Gold, D.A. Theuns, and B.P. Knight et al. Head-to-head comparison of arrhythmia discrimination performance of subcutaneous and transvenous ICD arrhythmia detection algorithms: the START study J Cardiovasc Electrophysiol 23 2012 359 366
5. J. Köbe, F. Reinke, and C. Meyer et al. Implantation and follow-up of totally subcutaneous versus conventional implantable cardioverter- defibrillators: a multicenter case-control study Heart Rhythm 10 2013 29 36
6. L.R. Olde Nordkamp, L. Dabiri Abkenari, and Boersma et al. The entirely subcutaneous implantable cardioverter-defibrillator: initial clinical experience in a large Dutch cohort J Am Coll Cardiol 60 2012 1933 1939
7. L. Dabiri Abkenari, D.A. Theuns, and S.D. Valk et al. Clinical experience with a novel subcutaneous implantable defibrillator system in a single center Clin Res Cardiol 100 2011 737 744
8. J.W. Jarman, K. Lascelles, T. Wong, V. Markides, J.R. Clague, and J. Till Clinical experience of entirely subcutaneous implantable cardioverter- defibrillators in children and adults: cause for caution Eur Heart J 33 2012 1351 1359
9. A. Aydin, F. Hartel, and M. Schlüter et al. Efficacy of subcutaneous implantable cardioverter-defibrillator for prevention of sudden cardiac death: initial multicenter experience Circ Arrhythm Electrophysiol 5 2012 913 919
10. J.B. van Rees, C.J. Borleffs, and M.K. de Bie et al. Inappropriate implantable cardioverter-defibrillator shocks: incidence, predictors, and impact on mortality J Am Coll Cardiol 57 2011 556 562
11. A.J. Moss, C. Schuger, and C.A. Beck et al. Reduction in inappropriate therapy and mortality through ICD programming N Engl J Med 367 2012 2275 2283
12. B.L. Wilkoff, B.D. Williamson, and R.S. Stern et al. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study J Am Coll Cardiol 52 2008 541 550
13. J.P. Daubert, W. Zareba, and D.S. Cannom et al. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II J Am Coll Cardiol 51 2008 357 365
14. Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 2008;51:e1-e62.
15. L.R. Olde Nordkamp, R.E. Knops, and G.H. Bardy et al. Rationale and design of the PRAETORIAN trial: a Prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator therapy Am Heart J 163 2012 753 760
16. S.S. Pedersen, P. Lambiase, and L.V. Boersma et al. Evaluation oF FactORs ImpacTing CLinical Outcome and Cost EffectiveneSS of the S-ICD: design and rationale of the EFFORTLESS S-ICD Registry Pacing Clin Electrophysiol 35 2012 574 579
17. G.I. Galasko, S.C. Barnes, P. Collinson, A. Lahiri, and R. Senior What is the most cost-effective strategy to screen for left ventricular systolic dysfunction: natriuretic peptides, the electrocardiogram, hand-held echocardiography, traditional echocardiography, or their combination? Eur Heart J 27 2006 193 200
18. B.T. Montague, J.R. Ouellette, and G.K. Buller Retrospective review of the frequency of ECG changes in hyperkalemia Clin J Am Soc Nephrol 3 2008 324 330
19. SQ-RX Pulse Generator. A Component of the S-ICD System. User's Manual. Model 1010. San Clemente, CA: Cameron Health, Inc; 2009.
20. M. Alders, T.T. Koopmann, and I. Christiaans et al. Haplotype-sharing analysis implicates chromosome 7q36 harboring DPP6 in familial idiopathic ventricular fibrillation Am J Hum Genet 84 2009 468 476
21. P.P. Lupo, G. Pelissero, H. Ali, R. Sanghera, and R. Cappato Development of an entirely subcutaneous implantable cardioverter-defibrillator Prog Cardiovasc Dis 54 2012 493 497